A retrospective analysis of the sensitivity of nuclear imaging in detecting hepatic malignancies has been done. Effects of clinical and liver function test bias have been studied on the ascribed sensitivity. The clinicobiochemical bias raises the detection sensitivity from 66.7% to 90.7% (p less than 0.001) but decreases the specificity of nuclear imaging significantly (p less than 0.05).